Table 1.
Summary of enrollment and follow–up in a study of leptospirosis.
| No. (%) of patients
|
|||||
|---|---|---|---|---|---|
| Location | Enrolled | With clinical follow-up | With available results from leptospiral serologic testing | With Antileptospiral anti-bodies detecteda | With severe pulmonary involvement b |
| Urban | |||||
| Hospital de Apoyo Iquitos | |||||
| Inpatients | 45 | 26 (57.8) | 44 (97.8) | 24 (55) | 5 |
| Outpatients | 344 | 290 (84.3) | 306 (89.0) | 165 (53.9) | 2 |
| Subtotal | 389 | 316 (81.2) | 350 (90.0) | 54 (54)c | 7 |
| Rural | |||||
| Zungarococha | 59 | 57 (96.6) | 59 (100) | 31 (52.5%) | 0 |
| Varillal | 72 | 60 (83.3) | 72 (100) | 44 (61.1%) | 0 |
| Moralillo | 113 | 96 (85.0) | 107 (95.0) | 57 (53.2%) | 0 |
| Subtotal | 244 | 213 (87.3) | 238 (97.5) | 132 (55.4)c | 0 |
| Total | 633 | 529 (83.6) | 588 (92.9) | 321 (54.6) | 7 |
a
Of patients for whom at least 1 positive result was available from IgM ELISA or Microscopic Agglutination Testing (MAT); positivity was determined according to criteria mentioned in Materials and Methods.
b
Significantly different. P = .0141 for a one-sided alternative hypothesis (diff>0) and P = .0282 for a two-sided alternative hypothesis.
c
Not significantly different.